PL3319651T3 - Unaczynione urządzenia do perfuzji in vitro, sposoby ich wytwarzania i zastosowania - Google Patents

Unaczynione urządzenia do perfuzji in vitro, sposoby ich wytwarzania i zastosowania

Info

Publication number
PL3319651T3
PL3319651T3 PL16821889.9T PL16821889T PL3319651T3 PL 3319651 T3 PL3319651 T3 PL 3319651T3 PL 16821889 T PL16821889 T PL 16821889T PL 3319651 T3 PL3319651 T3 PL 3319651T3
Authority
PL
Poland
Prior art keywords
vascularized
fabricating
applications
methods
perfusion devices
Prior art date
Application number
PL16821889.9T
Other languages
English (en)
Inventor
Michael W. GOLWAY
James B. Hoying
Original Assignee
Advanced Solutions Life Sciences, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Solutions Life Sciences, Llc filed Critical Advanced Solutions Life Sciences, Llc
Publication of PL3319651T3 publication Critical patent/PL3319651T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/16—Microfluidic devices; Capillary tubes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14—Scaffolds; Matrices
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0691—Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Vascular Medicine (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
PL16821889.9T 2015-07-06 2016-07-06 Unaczynione urządzenia do perfuzji in vitro, sposoby ich wytwarzania i zastosowania PL3319651T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562188803P 2015-07-06 2015-07-06
US201662279019P 2016-01-15 2016-01-15
PCT/US2016/041034 WO2017007786A1 (en) 2015-07-06 2016-07-06 Vascularized in vitro perfusion devices, methods of fabricating, and applications thereof

Publications (1)

Publication Number Publication Date
PL3319651T3 true PL3319651T3 (pl) 2022-11-14

Family

ID=57686133

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16821889.9T PL3319651T3 (pl) 2015-07-06 2016-07-06 Unaczynione urządzenia do perfuzji in vitro, sposoby ich wytwarzania i zastosowania

Country Status (10)

Country Link
US (2) US10392595B2 (pl)
EP (1) EP3319651B1 (pl)
JP (1) JP6917975B2 (pl)
KR (1) KR102530274B1 (pl)
AU (1) AU2016289944B2 (pl)
DK (1) DK3319651T3 (pl)
ES (1) ES2922905T3 (pl)
IL (1) IL256673B (pl)
PL (1) PL3319651T3 (pl)
WO (1) WO2017007786A1 (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3060060B1 (en) * 2013-10-25 2019-07-03 TeVido BioDevices Tissue engineered devices and methods for making same
WO2018132720A1 (en) * 2017-01-13 2018-07-19 The Penn State Research Foundation Organ models
JP7144434B2 (ja) * 2017-03-15 2022-09-29 アスペクト バイオシステムズ リミティド 繊維構造をプリントするためのシステム及び方法
EP3609996A4 (en) 2017-04-14 2021-04-14 Advanced Solutions Life Sciences, LLC IN VITRO VASCULARIZED NETWORKS OF LIVING CELLS
US11035740B1 (en) * 2017-07-31 2021-06-15 Prasidiux, Llc Stimulus indicating device employing thermoreversible amphiphilic gels
WO2019060318A1 (en) * 2017-09-19 2019-03-28 Cornell Univeristy MANUFACTURING A BIOMEMETIC PLATFORM SYSTEM AND METHODS OF USE
WO2019089596A1 (en) * 2017-10-30 2019-05-09 Lawrence Livermore National Security, Llc Polymeric encapsulation of whole cells as bioreactors
GB201801582D0 (en) * 2018-01-31 2018-03-14 Univ Leuven Kath Devices and methods for three-dimensional growth of cells
KR102441083B1 (ko) 2018-03-08 2022-09-06 현대자동차주식회사 크랭크샤프트용 댐퍼풀리
KR102737989B1 (ko) * 2018-03-26 2024-12-05 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 멀티레인 혈관구조용 시스템 및 방법
CN110607271B (zh) * 2018-06-14 2023-01-20 中国科学院大连化学物理研究所 一种基于微加工技术的体外血管化3d组织的制备方法
CN110713921B (zh) * 2018-07-13 2022-12-20 复旦大学 一套体外动态的药物代谢孵育系统
SE543308C2 (en) * 2018-12-11 2020-11-24 Cellink Ab Microfluidic device facilitating perfusion of mammalian and human tissue constructs
WO2020185576A1 (en) * 2019-03-08 2020-09-17 Advanced Solutions Life Sciences, Llc Modular and expandable low flow pumping assemblies
WO2020205567A1 (en) * 2019-03-29 2020-10-08 Advanced Solutions Life Sciences, Llc Systems and methods for biomedical object segmentation
WO2020257539A1 (en) * 2019-06-18 2020-12-24 3D Biolabs, Llc Systems and methods for fabricating a microchannel vascular network device and seeding a microchannel
GB202004177D0 (en) * 2020-03-16 2020-05-06 Imp College Innovations Ltd Device for perfusion and preservation of tissue specimens ex vivo
AU2021268007A1 (en) * 2020-05-05 2022-11-24 3D Systems, Inc. Microcosm bio-scaffold and applications thereof
KR102520786B1 (ko) * 2020-05-27 2023-04-13 한국재료연구원 3차원 구조체 내부 관류 가능 미세 혈관 생성을 위한 바이오리액팅 시스템
WO2022015854A2 (en) * 2020-07-15 2022-01-20 Advanced Solutions Life Sciences, Llc Methods of identifying therapeutic targets for treating angiogenesis
US12281333B2 (en) * 2020-11-04 2025-04-22 University Of Kansas Renal tube assay device and methods of manufacture and use
US20240084237A1 (en) * 2021-01-15 2024-03-14 The Trustees Of Indiana University A device having a support structure for creating a hollow, three-dimensional organoids and cultures
WO2022187632A1 (en) * 2021-03-05 2022-09-09 Advanced Solutions Life Sciences, Llc Models and methods to establish perfused vascularized tissues in three-dimensional in vitro culture
WO2022251643A1 (en) * 2021-05-27 2022-12-01 The Regents Of The University Of California Superporous gel matrix for encapsulation of cells
CA3233071A1 (en) * 2021-09-24 2023-03-30 3D Systems, Inc. Manifolds, systems and methods for conducting biological studies under flow
WO2023133523A2 (en) * 2022-01-07 2023-07-13 South Dakota Board Of Regents Physiologically-relevant, serum-free in vitro angiogenesis platform
US20240368511A1 (en) * 2022-01-24 2024-11-07 Belement Inc. Microfluidic device for manufacturing bioscaffold and use thereof
EP4577636A1 (en) * 2022-08-26 2025-07-02 Chunguang Xia System and method for perfusion bioreactor for 3d cell culture
KR102859746B1 (ko) * 2023-01-13 2025-09-15 전남대학교산학협력단 혈관-근육 공배양 장치 및 그 제조방법
IT202300011436A1 (it) * 2023-06-06 2024-12-06 Bio System Lab S R L Modello di pelle biostampato, relativo processo di stampa tridimensionale e dispositivo di perfusione diretta provvisto di tale modello
WO2025107170A1 (zh) * 2023-11-22 2025-05-30 清华大学 一种促微血管形成的生物墨水及其制备方法与应用
WO2026006691A1 (en) * 2024-06-28 2026-01-02 Ronawk, Inc. Generation of personalized microvasculature from interconnecting porous hydrogel blocks
WO2026006690A1 (en) * 2024-06-28 2026-01-02 Ronawk, Inc. Ex vivo tumor genesis of patient cancers using patient tissues cultivated in interconnecting porous hydrogel blocks
WO2026006692A1 (en) * 2024-06-28 2026-01-02 Ronawk, Inc. Mammalian tissue generation using interconnecting porous hydrogel blocks
WO2026027452A1 (en) * 2024-07-29 2026-02-05 Julius-Maximilians-Universität Würzburg, In Vertretung Des Freistaates Bayern 3d perfusable tissue construct with crosslinking initiator

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02261375A (ja) * 1989-04-03 1990-10-24 Terumo Corp 血管新生活性を有する細胞および血管新生活性物ならびにその製造方法
US7029838B2 (en) 2001-03-30 2006-04-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized contructs for implantation to provide blood perfusion
US7052829B2 (en) * 2001-03-30 2006-05-30 The Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized constructs for implantation to provide blood perfusion
AU2003214155A1 (en) 2002-03-12 2003-09-29 The Regents Of The University Of California Vascularized tissue for transplantation
US8663625B2 (en) 2004-10-15 2014-03-04 Cornell Research Foundation Diffusively permeable monolithic biomaterial with embedded microfluidic channels
US8003388B2 (en) * 2006-03-24 2011-08-23 Nortis, Inc. Method for creating perfusable microvessel systems
US7622298B2 (en) * 2006-03-24 2009-11-24 Norits, Inc. Method for creating perfusable microvessel systems
EP2200931B1 (en) * 2007-09-19 2017-06-07 The Charles Stark Draper Laboratory, Inc. Microfluidic structures with circular cross-section
US9226494B2 (en) * 2008-09-19 2016-01-05 University Of Louisville Research Foundation, Inc. Bioreactors, systems, and methods for vascularizing tissue constructs
US9267099B2 (en) * 2010-03-15 2016-02-23 Indiana University Research And Technology Corporation Engineered lumenized vascular networks and support matrix
US20150231182A1 (en) * 2012-09-07 2015-08-20 University Of Louisville Research Foundation, Inc. Cell systems and methods for delivering disease-specific therapies
JP2015062392A (ja) * 2013-09-26 2015-04-09 学校法人東京電機大学 毛細血管の製造方法および毛細血管の製造装置
WO2015069619A1 (en) * 2013-11-05 2015-05-14 President And Fellows Of Harvard College Method of printing a tissue construct with embedded vasculature
CN107427537A (zh) 2015-03-03 2017-12-01 哈佛学院院长及董事 产生功能性人体组织的方法

Also Published As

Publication number Publication date
WO2017007786A1 (en) 2017-01-12
US20170009194A1 (en) 2017-01-12
AU2016289944B2 (en) 2020-05-07
US20190330583A1 (en) 2019-10-31
KR102530274B1 (ko) 2023-05-08
ES2922905T3 (es) 2022-09-21
CA2991297A1 (en) 2017-01-12
EP3319651A1 (en) 2018-05-16
EP3319651B1 (en) 2022-05-11
IL256673A (en) 2018-02-28
KR20180027553A (ko) 2018-03-14
IL256673B (en) 2021-12-01
US10392595B2 (en) 2019-08-27
JP6917975B2 (ja) 2021-08-11
AU2016289944A1 (en) 2018-02-01
EP3319651A4 (en) 2018-10-24
DK3319651T3 (da) 2022-07-18
JP2018532371A (ja) 2018-11-08

Similar Documents

Publication Publication Date Title
IL256673A (en) In vitro vascular perfusion devices, methods and their applications
IL259370A (en) Graphene-metal composite material with high conductivity and methods for production
IL286785B (en) Enzymes and their applications
IL254458B (en) Anti-pdl1 antibodies, activatable anti-pdl1 antibodies and methods of using them
ZA201602792B (en) Microfluidic devices, and methods of making and using the same
SG10201913767VA (en) Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof
HUE042640T2 (hu) CFTR-mRNS-készítmények, valamint kapcsolódó eljárások és alkalmazások
EP2956903A4 (en) DISTRIBUTED CLOUD SERVICES AND USES THEREOF
ZA201507027B (en) Self-sealing balloons and related components and methods of manufacturing
IL249384A0 (en) Methods for producing cells using perfusate and their use
ZA201801549B (en) Acetamide thienotriazoldiazepines and uses thereof
SG11201509733PA (en) Multiple-power multiple-dosage accelerators, rapid examination systems and rapid examination methods thereof
SI3265123T1 (sl) Protitelesa, uporabe in postopki
HUE062176T2 (hu) Mûtrágya készítmények, eljárás ezek elõállítására és alkalmazásuk
HUE045150T2 (hu) Anti-CD26 antitestek és alkalmazásaik
SG11201510209SA (en) Cell populations, methods of transdifferention and methods of use thereof
HUE046306T2 (hu) Katekollal funkcionalizált mágneses nanorészecskék, elõállításuk és alkalmazásuk
DK2994150T3 (da) Probiotika og fremgangsmåde til anvendelse
SG11201705748SA (en) Anti-glycoprotein antibodies and uses thereof
TWI563628B (en) Semiconductor structure and method of fabricating the same
GB201515368D0 (en) Composite members and methods of manufacturing same
EP2970175A4 (en) CELLULAR ADDUCTS, METHODS OF MAKING SAME, AND USES THEREOF
GB201315743D0 (en) Provision and uses of wettability modifiers
GB201509277D0 (en) Production of 3-alkylphenols and uses thereof
GB201502489D0 (en) Cells, preparation, uses, methods and components